Pediatric Neurology Briefs (Jul 2005)

Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH

  • J Gordon Millichap

DOI
https://doi.org/10.15844/pedneurbriefs-19-7-5
Journal volume & issue
Vol. 19, no. 7
pp. 52 – 52

Abstract

Read online

The continuity of methylphenidate (MPH) therapy for ADHD in young Medicaid beneficiaries (ages 6 to 17 years) treated with immediate-release (IR) or extended-release (ER) MPH formulations was compared in an analysis of statewide California Medicaid claims (2000-2003) conducted at Columbia University, New York; University of Pennsylvania, Philadelphia; and McNeil Pharmaceuticals, Fort Washington, PA.

Keywords